CELL SIGNALING TECHNOLOGY search Cell Signaling Technology CTNNB1 products
includes other brands or spellings
|
| wb | | Cell Signaling phospho-beta-catenin antibody was used in western blot to study the role of IKK alpha in mitogenic signaling. |
| wb | | Cell Signaling polyclonal anti-phospho-beta-catenin antibody that recoginzes the phosphorylation site at Ser33, Ser37, and Thr41 of beta-catenin was used in western blot to study effect on beta-catenin phosphorylation by GSK-3 mutants in intact cells. |
| wb | | Cell Signaling Technology beta-catenin antibody was used in western blot to study TGF beta-mediated chondrogenesis of human mesenchymal progenitor cells. |
SIGMA-ALDRICH search Sigma-Aldrich CTNNB1 products
includes other brands or spellings
|
| ic, wb | | Sigma rabbit polyclonal anti-β-catenin antibody (C2206) was used in COS cells with full-length human β-catenin and human SCC9 cells, and which were respectively used in western blot and immunocytochemistry to study the biological functions of PKP2. |
| ic, wb | | Sigma rabbit polyclonal antibody to beta-catenin was used in western blot and immunocytochemistry to study the role of the deubiquitylating enzyme FAM in the trafficking of beta-catenin and E-cadherin in epithelia. |
| ic | | Sigma rabbit anti-human beta-catenin antibody was used in human cells and in immunocytometry to study the involvement of transendothelial migration of melanoma cells in N-cadherin-mediated adhesion and activation of the beta-catenin signaling pathway. |
| ic | | Sigma polyclonal anti-beta-catenin antibody was used in immunocytochemistry to study the role of casein kinase I epsilon in Dvl-1 and Frat-1 interaction and in beta-catenin accumulation. |
| ih, ip, wb | | Sigma rabbit polyclonal anti-ß-catenin antibody was used in paraffin sections from human colonic polyps, ACF, serrated adenomas and human adenomatous polyp biopsies, HT 29 colorectal cancer cells, which were respectively used in immunohistochemistry and immunoprecipitation, western blot, to study the role of P-cadherin in colonic polyp formation. |
| ih | | Sigma Chemical Co. anti-pan-ß-catenin antibody (clone 15B8) was used in paraffin sections from human and in immunohistochemistry to study the role for aberrant Wnt/ß-catenin pathway activation in idiopathic pulmonary fibrosis. |
| wb | | Sigma beta-catenin monoclonal antibody was used in Western blot to study the interaction between EB1 and p150Glued. |
| wb | | Sigma anti-beta-catenin antibody was used in western blot to study that MAGI1 recruits Dll1 to cadherin-based adherens junctions and stabilizes it on the cell surface. |
| wb | | Sigma-Aldrich rabbit polyclonal beta-catenin antibody was used in western blot to study the effect of E-cadherin on fibroblast growth factor receptor 1. |
SANTA CRUZ BIOTECHNOLOGY search Santa Cruz Biotechnology CTNNB1 products
includes other brands or spellings
|
| chip, ip, wb | | Santa Cruz Biotechnology rabbit polyclonal anti-beta-catenin antibody was used in human SW480 cells and in western blot, immunoprecipitation, ChIP assay to study the interactions between different domains of CoCoA and beta-catenin or GRIP1. |
| ic, wb | | SCBT b-catenin antibody was used in western blot and immunocytochemistry to study the regulation of E-cadherin shedding and beta-catenin translocation by ADAM10. |
| ic | | Santa Cruz Biotechnology anti-beta-catenin antibody was used in immunocytochemistry to detect expression of beta-catenin in chondrocytes transfected with alpha-catenin or GFP-tagged beta-catenin. |
| ih | | Santa Cruz Biotechnology anti-beta-catenin antibody was used in immunohistochemistry to study the role of wnt11 signaling in proliferation, transformation, and migration of IEC6 intestinal epithelial cells. |
| ih | | Santa Cruz Biotechnology anti-beta-catenin antibody was used in immunohistochemistry to study that MAGI1 recruits Dll1 to cadherin-based adherens junctions and stabilizes it on the cell surface. |
| ip, wb | | Santa Cruz Biotechnology antibody to beta- catenin was used in immunoprecipitation to isolate beta- catenin from human HaCaT cells, and in western blot to detect the amount of beta- catenin in HaCaT cells. |
| ip, wb | | Santa Cruz Biotechnology polyclonal anti-beta-catenin antibody was used in western blot and immunoprecipitation to study the effect of N-acetylglucosaminyltransferase V expression levels on cadherin-associated homotypic cell-cell adhesion and intracellular signaling pathways in HT1080 human fibrosarcoma cells. |
| ip | | Santa Cruz Biotechnology rabbit polyclonal antibody against the C terminus of beta-catenin (H102) was used in immunoprecipitation to isolate beta-catenin from human HEK293 and SW480 cell lines. |
| wb | | Santa Cruz Biotechnology monoclonal anti-beta-catenin antibody was used in western blot to study HFz6 represses the canonical Wnt pathway by transmitting an antagonistic signaling cascade. |
| wb | | Santa Cruz Biotechnology mouse anti-beta-catenin antibody sc-7963 was used in human HeLa and HEK293T cells and in western blot to study the effect of Dapper 1 on Wnt signaling. |
| wb | | Santa Cruz Biotechnology antibody against total beta-catenin was used in western blot to detect total beta-catenin in human MCF-7 cells. |
| wb | | Santa Cruz Biotechnology antibody to ß-catenin (H102) was used in western blot as a control protein to study the metabolic instability of RECQL4 in HeLa cells through UBR1 and UBR2 mediated polyubiquitylation and proteasome-dependent degradation of substrates of the N-end rule pathway. |
BD BIOSCIENCES search BD Biosciences CTNNB1 products
includes other brands or spellings
|
| chip, ip, wb | | BD Transduction Laboratories beta-catenin antibody was used in western blot and immunoprecipitation to study the interaction of beta-catenin and TIF2/GRIP1. |
| chip, wb | | Transduction Laboratories monoclonal beta-catenin antibody was used in western blot and ChIP assay to study the effect of Wnt-7a in corneal epithelial cells during wound healing. |
| ic, ih, wb | | BD Transduction Laboratories mouse monoclonal anti-ß-catenin antibody was used in western blot, immunocytochemistry and immunohistochemistry to study the aberrant localization of ß-catenin correlated with overexpression of its target gene in human papillary thyroid cancer. |
| ic, ih | | BD beta-catenin antibody was used in immunohistochemistry and immunocytochemistry to investigate the expression of beta-catenin and c-myc in chronic wounds. |
| ic, ip, wb | | Transduction Laboratories anti-beta-catenin monoclonal antibody was used in western blot and immunoprecipitation to study the protein tyrosine phosphatase Pez as a major phosphatase of adherens junctions and dephosphorylates beta-catenin. |
| ic, wb | | Transduction Laboratories mouse monoclonal anti-beta-catenin antibody was used in western blot and immunocytochemistry to detect beta-catenin in VEC null and VEC positive cells. |
| ic, wb | | Transduction Laboratories monoclonal beta-catenin antibody was used in western blot and immunocytochemistry to study the association of plakoglobin with desmosomes and adherens junction components. |
| ic, wb | | BD Transduction Laboratories mouse monoclonal antibody to beta-catenin was used in western blot to study the role of the deubiquitylating enzyme FAM in the trafficking of beta-catenin and E-cadherin in epithelia. |
| ic, wb | | Transduction Laboratories anti-ß-catenin was used in immunostaining and western blot to study the interaction of lp-dlg and ß-catenin. |
| ic | | Transduction Laboratories mouse anti- beta-catenin was used in immunocytochemistry to determine the localization of beta-catenin in normal human keratinocytes (NHKs). |
| ic | | Transduction Laboratory anti-beta catenin antibody was used in immunocytochemistry to study human lung epithelial and endothelial barrier. |
| ic | | Transduction Laboratories monoclonal beta-catenin antibody was used in immunocytochemistry to study L1 expression in colon cancers. |
| ic | | Transduction Labs beta-catenin (C19220) antibody was used in immunocytochemistry to study subcellular localization of LGN during mitosis. |
| ic | | BD Biosciences mouse monoclonal beta-catenin antibody was used in immunocytochemistry to study the mechanism of Rac activation induced by S1P. |
| ic | | BD Transduction Laboratories mouse monoclonal anti-ß-catenin was used in immunostaining as a marker of the lateral membrane to study the wildtype and mutant Myc-CRB3 constructs expressed in MDCK cells. |
| ih, wb | | Transduction Laboratories antibody which recognizes β-catenin was used in western blot and immunohistochemistry to study the deregulation of pregnancy specific β1 glycoprotein 9 early during colorectal carcinogenesis through detecting differential gene expression. |
| ih, wb | | BD Transduction Laboratories beta-catenin antibody was used in western blot and immunohistochemistry to study the effect of Wnt-7a on articular chondrocytes. |
| ih | | Transduction Laboratories monoclonal anti-ß-catenin antibody was used in immunohistochemistry to study a mouse model of hepatocellular carcinoma. |
| ih | | Transduction Labs anti-ß-catenin antibody (clone 14) was used in paraffin sections from human colonic polyps, ACF, serrated adenomas and in immunohistochemistry to study the role of P-cadherin in colonic polyp formation. |
| ih | | Becton-Dickinson Transduction Laboratories monoclonal anti-ß-catenin antibody was used in paraffin sections from human and in immunohistochemistry to study the expression of MUC1 and nuclear ß-catenin in colorectal cancer and the correlations of them with tumor prognosis. |
| ih | | Transduction Laboratories anti-beta-catenin antibody was used in immunohistochemistry to detect beta-catenin in human SHEP cells. |
| ih | | BD Transduction Laboratories monoclonal beta-catenin antibody was used in immunohistochemistry to study the localization of drebrin complexes in mesangial cells and podocytes of renal glomeruli. |
| ih | | BD Transduction Laboratories monoclonal anti-human ß-catenin antibody was used in immunohistochemisty to study the association of matrilysin-2 (MMP-26) expression with tumor progression and activation of MMP-9 in esophageal squamous cell carcinoma. |
| ih | | Transduction Laboratories monoclonal anti-beta-catenin antibody was used in immunohistochemistry to study the role of Kir4.1 in the K+ recycling pathway. |
| ih | | BD Transduction Laboratories b-catenin antibody was used in immunohistochemistry to study b-catenin expressionin in hepatocellular carcinoma. |
| ip, wb | | BD Biosciences monoclonal anti-β-catenin antibody was used in western blot and immuonprecipitation to study the effect of Wnt4 overexpression on normal testicular vasculature and testosterone synthesis. |
| ip, wb | | BD Transduction Laboratories mouse monoclonal anti-beta-catenin antibody was used in western blot and immunoprecipitation to detect expression of beta-catenin in H28 cells transfected with beta-catenin. |
| ip, wb | | BD Biosciences beta-catenin (clone 14, mIgG1) antibody was used in western blot and immunoprecipitation to study the migratory-adhesive switch in Ewing's Sarcoma Cells triggered by matrix metalloproteinase-9 silencing. |
| ip, wb | | Transduction Laboratories antibody raised against beta-catenin was used in immunoprecipitation to isolate beta-catenin and in western blot to detect the expression of beta-catenin in human Caco-2/15 cells. |
| ip, wb | | Transduction Laboratories mouse monoclonal beta-catenin antibody was used in western blot and immunoprecipitation to study the effect of protein kinase CKII on catenins. |
| ip, wb | | Transduction Laboratories monoclonal antibody against ß-catenin was used in western blot and immunoprecipitation to study the function of p120 catenin-associated Fer and Fyn tyrosine kinases to regulate beta-Catenin Tyr-142 phosphorylation and beta-catenin-alpha-catenin interaction. |
| ip, wb | | BD Transduction Laboratories mouse monoclonal antibody which recognizes beta-catenin was used in immunoprecipitation and western blot to study the interaction of synaptic scaffolding molecule and beta-catenin. |
| ip | | Transduction Laboratories monoclonal anti-β-catenin antibody (C19220) was used in COS cells with full-length human β-catenin and in immunoprecipitation to study the biological functions of PKP2. |
| wb | | BD Transduction b-Catenin antibody was tested in western blot by Abminer. |
| wb | | Transduction Laboratories anti-beta-catenin mouse monoclonal IgG (1:1000) (C19222) was used in western blot to study the diversion of nuclear beta-Catenin from TCF. |
| wb | | Transduction Laboratories anti-beta-catenin antibody was used in immunocytochemistry to study a novel GTPase-activating protein for cdc42 and rac1 involved in the beta-catenin-N-cadherin and N-methyl-D-aspartate receptor signaling. |
| wb | | BD Transduction Laboratories mouse monoclonal anti-beta-catenin antibody was used in western blot to study the interaction between trichoplein and keratin filament-biding protein. |
| wb | | Transduction Laboratories monoclonal anti-β-catenin antibody was used in western blot to study the function of DRO1 in colon and pancreatic cancer cells. |
| wb | | Transduction Laboratories anti-β-catenin antibody (catalog no. 610153) was used in cultured human cell lines and in western blot to study the effect of gadd45β3' enhancer on SMAD3- and SMAD4-dependent transcriptional induction by transforming growth factor β. |
| wb | | BD Biosciences monoclonal anti-β-catenin antibody was used in cultured human MCF-7 、MDA-MB-468 cells and in western blot to study the effect of interactions between Smac/DIABLO Peptides and XIAP and cIAP1 on the anti- apoptosis and antiproliferation which were induced by chemotherapeutic agents. |
| wb | | BD Biosciences Pharmingen anti-catenin beta antibody was used in human MDA-MB-435 cells, MDA-MB-231 cells and in western blot to study the roles for two regions of cadherin cytoplasmic domains in suppressing motility of a mammary carcinoma cell line. |
| wb | | Transduction Laboratories monoclonal anti-beta-catenin antibody was used in human A549 cells and in western blot to study the interaction between the receptor protein-tyrosine phosphatase PTPµ and IQGAP1. |
| wb | | Transduction Laboratories mouse monoclonal anti-human beta-catenin antibody was used in human cells and in western blot to study the involvement of transendothelial migration of melanoma cells in N-cadherin-mediated adhesion and activation of the beta-catenin signaling pathway. |
| wb | | BD Transduction Laboratories mouse monoclonal beta-catenin antibody was used in western blot to study the effect of E-cadherin on fibroblast growth factor receptor 1. |
| wb | | Transduction Laboratories mouse monoclonal anti beta-catenin antibody (C19220) was used in western blot to study The zinc- and calcium-binding S100B interaction and co-localization with IQGAP1 during dynamic rearrangement of cell membranes. |
| wb | | BD Transduction Laboratories anti-beta-catenin antibody was used in western blot as the loading control to study the role of protein phosphatase 5 in ATR-mediated checkpoint activation. |
| wb | | Transduction Laboratories beta-catenin antibody was used in western blot to study the role of IKK alpha in mitogenic signaling. |
| wb | | Transduction Laboratories monoclonal anti-beta-catenin antibody was used in western blot to study the role of casein kinase I epsilon in Dvl-1 and Frat-1 interaction and in beta-catenin accumulation. |
| wb | | BD Transduction Laboratories beta-catenin antibody was used in western blot to study transcriptional stimulation in colon cancer by prostaglandin E2. |
| wb | | BD Transduction Laboratories beta-catenin C19220 antibody was used in western blot to characterize a new peroxisome proliferator-activated receptor gamma isoform. |
| wb | | Transduction Laboratories anti-beta-catenin (C19220) antibody was used in western blot to study constitutive regulation of beta-catenin signaling functions. |
MILLIPORE search Millipore CTNNB1 products
includes other brands or spellings
|
| ic | | Upstate Biotechnology beta-catenin (clone 2H4A7, mIgG1) antibody was used in immunocytochemistry to study the migratory-adhesive switch in Ewing's Sarcoma Cells triggered by matrix metalloproteinase-9 silencing. |
| ih | | Chemicon CTNNB1 antibody was tested in immunohistochemistry by HPA (CAB001950) . |
| ih | | Upstate CTNNB1 antibody was tested in immunohistochemistry by HPA (CAB001950) . |
| ih | | Upstate Cell Signalling Solutions anti-active-beta-catenin that recognizes the dephosphorylated form of the protein was used in immunohistochemistry to study expression of sFRP-4 and beta-catenin in human colorectal carcinoma.. |
| wb | | Upstate Biotechnology anti-beta-catenin antibody was used in western blot to study a novel GTPase-activating protein for cdc42 and rac1 involved in the beta-catenin-N-cadherin and N-methyl-D-aspartate receptor signaling. |
| wb | | Upstate beta-catenin antibody was used in western blot to study PITX2, beta-catenin and LEF-1 interaction. |
INVITROGEN search Invitrogen CTNNB1 products
includes other brands or spellings
|
| ih, ip, wb | | Zymed Laboratories rabbit monoclonal anti-mammalian beta-catenin antibody was used in western blot, immunoprecipitation and immunohistochemistry to examine the influence of transforming growth factor (TGF) -ß1 on proximal tubular epithelial cell-cell interaction, with particular emphasis on the regulation of adherens junction complex formation. |
| ip | | Zymed Laboratories beta-catenin antibody was used in immunoprecipitation to study E-cadherin proteolytic cleavage in prostate and mammary epithelial cells. |
ALEXIS search Alexis CTNNB1 products
includes other brands or spellings
|
| ic, wb | | Alexis antibody against unphosphorylated beta-catenin was used in western blot to detect beta-catenin and in immunocytochemistry to investigate the distribution of β-catenin in human MCF-7 cells. |
AG SCIENTIFIC
|
| ic | | AG Scientific mouse monoclonal anti-dephosphorylated beta-catenin antibody was used in human cells and in immunocytometry to study the involvement of transendothelial migration of melanoma cells in N-cadherin-mediated adhesion and activation of the beta-catenin signaling pathway. |
BECTON-DICKINSON TRANSDUCTION LABORATORIES
|
| ih | | Becton-Dickinson Transduction Laboratories monoclonal anti-ß-catenin antibody was used in paraffin sections from human and in immunohistochemistry to study the expression of MUC1 and nuclear ß-catenin in colorectal cancer and the correlations of them with tumor prognosis. |
UPSTATE CELL SIGNALLING SOLUTIONS
|
| ih | | Upstate Cell Signalling Solutions anti-active-beta-catenin that recognizes the dephosphorylated form of the protein was used in immunohistochemistry to study expression of sFRP-4 and beta-catenin in human colorectal carcinoma.. |
Articles Reviewed |
| 1. Xinyu Chen et al. Protein binding and functional characterization of plakophilin 2. Evidence for its diverse roles in desmosomes and beta -catenin signaling. 2002 |
| 2. Wataru Nishimura et al. Interaction of synaptic scaffolding molecule and Beta -catenin. 2002 |
| 3. R G Hardy et al. Aberrant P-cadherin expression is an early event in hyperplastic and dysplastic transformation in the colon. 2002 |
| 4. Akikazu Fujita et al. Specific localization of an inwardly rectifying K(+) channel, Kir4.1, at the apical membrane of rat gastric parietal cells; its possible involvement in K(+) recycling for the H(+)-K(+)-pump. 2002 |
| 5. Maria Grazia Lampugnani et al. VE-cadherin regulates endothelial actin activating Rac and increasing membrane association of Tiam. 2002 |
| 6. Thilo Hagen et al. Expression and characterization of GSK-3 mutants and their effect on beta-catenin phosphorylation in intact cells. 2002 |
| 7. Ya Chung Tian et al. Interaction between the transforming growth factor-beta type II receptor/Smad pathway and beta-catenin during transforming growth factor-beta1-mediated adherens junction disassembly. 2002 |
| 8. Katrina Nicholes et al. A mouse model of hepatocellular carcinoma: ectopic expression of fibroblast growth factor 19 in skeletal muscle of transgenic mice. 2002 |
| 9. Katsu Ishigaki et al. Aberrant localization of beta-catenin correlates with overexpression of its target gene in human papillary thyroid cancer. 2002 |
| 10. Christina R Arnt et al. Synthetic Smac/DIABLO peptides enhance the effects of chemotherapeutic agents by binding XIAP and cIAP1 in situ. 2002 |
| 11. Gaelh Ouengue Mbele et al. The zinc- and calcium-binding S100B interacts and co-localizes with IQGAP1 during dynamic rearrangement of cell membranes. 2002 |
| 12. J M Askham et al. Evidence that an interaction between EB1 and p150(Glued) is required for the formation and maintenance of a radial microtubule array anchored at the centrosome. 2002 |
| 13. Jonathan Rios-Doria et al. The role of calpain in the proteolytic cleavage of E-cadherin in prostate and mammary epithelial cells. 2003 |
| 14. Stephan Bek et al. Protein kinase CKII regulates the interaction of beta-catenin with alpha-catenin and its protein stability. 2002 |
| 15. Toshio Okabe et al. RICS, a novel GTPase-activating protein for Cdc42 and Rac1, is involved in the beta-catenin-N-cadherin and N-methyl-D-aspartate receptor signaling. 2003 |
| 16. Shin-ichiro Hino et al. Casein kinase I epsilon enhances the binding of Dvl-1 to Frat-1 and is essential for Wnt-3a-induced accumulation of beta-catenin. 2003 |
| 17. Chris Albanese et al. IKKalpha regulates mitogenic signaling through transcriptional induction of cyclin D1 via Tcf. 2003 |
| 18. Jose Piedra et al. p120 Catenin-associated Fer and Fyn tyrosine kinases regulate beta-catenin Tyr-142 phosphorylation and beta-catenin-alpha-catenin Interaction. 2003 |
| 19. Makoto Wakabayashi et al. Interaction of lp-dlg/KIAA0583, a membrane-associated guanylate kinase family protein, with vinexin and beta-catenin at sites of cell-cell contact. 2003 |
| 20. Marco Chilosi et al. Aberrant Wnt/beta-catenin pathway activation in idiopathic pulmonary fibrosis. 2003 |
| 21. Wiebke K Peitsch et al. Cell biological and biochemical characterization of drebrin complexes in mesangial cells and podocytes of renal glomeruli. 2003 |
| 22. Jia-Hao Xiao et al. Adenomatous polyposis coli (APC)-independent regulation of beta-catenin degradation via a retinoid X receptor-mediated pathway. 2003 |
| 23. Michael H Roh et al. The Crumbs3-Pals1 complex participates in the establishment of polarity in mammalian epithelial cells. 2003 |
| 24. Carol Wadham et al. The protein tyrosine phosphatase Pez is a major phosphatase of adherens junctions and dephosphorylates beta-catenin. 2003 |
| 25. Josiane Sancéau et al. Matrix metalloproteinase-9 silencing by RNA interference triggers the migratory-adhesive switch in Ewing's sarcoma cells. 2003 |
| 26. Richard Tuli et al. Transforming growth factor-beta-mediated chondrogenesis of human mesenchymal progenitor cells involves N-cadherin and mitogen-activated protein kinase and Wnt signaling cross-talk. 2003 |
| 27. Rachna Kaushik et al. Subcellular localization of LGN during mitosis: evidence for its cortical localization in mitotic cell culture systems and its requirement for normal cell cycle progression. 2003 |
| 28. Brian K Jordan et al. Wnt4 overexpression disrupts normal testicular vasculature and inhibits testosterone synthesis by repressing steroidogenic factor 1/beta-catenin synergy. 2003 |
| 29. Susana Miravet et al. Tyrosine phosphorylation of plakoglobin causes contrary effects on its association with desmosomes and adherens junction components and modulates beta-catenin-mediated transcription. 2003 |
| 30. Mary Fedor-Chaiken et al. Two regions of cadherin cytoplasmic domains are involved in suppressing motility of a mammary carcinoma cell line. 2003 |
| 31. Hua-Bei Guo et al. N-acetylglucosaminyltransferase V expression levels regulate cadherin-associated homotypic cell-cell adhesion and intracellular signaling pathways. 2003 |
| 32. Michael B Major et al. Identification of a gadd45beta 3' enhancer that mediates SMAD3- and SMAD4-dependent transcriptional induction by transforming growth factor beta. 2004 |
| 33. Patrick Laprise et al. Human homolog of disc-large is required for adherens junction assembly and differentiation of human intestinal epithelial cells. 2004 |
| 34. Rachael Z Murray et al. The FAM deubiquitylating enzyme localizes to multiple points of protein trafficking in epithelia, where it associates with E-cadherin and beta-catenin. 2004 |
| 35. Tamar Golan et al. The human Frizzled 6 (HFz6) acts as a negative regulator of the canonical Wnt. beta-catenin signaling cascade. 2004 |
| 36. Sang-Gu Hwang et al. Wnt-7a causes loss of differentiated phenotype and inhibits apoptosis of articular chondrocytes via different mechanisms. 2004 |
| 37. Lillian Ouko et al. Wnt11 signaling promotes proliferation, transformation, and migration of IEC6 intestinal epithelial cells. 2004 |
| 38. Stephan E Baldus et al. MUC1 and nuclear beta-catenin are coexpressed at the invasion front of colorectal carcinomas and are both correlated with tumor prognosis. 2004 |
| 39. Kamon Kawkitinarong et al. Differential regulation of human lung epithelial and endothelial barrier function by thrombin. 2004 |
| 40. Jinhu Yin et al. RECQL4, mutated in the Rothmund-Thomson and RAPADILINO syndromes, interacts with ubiquitin ligases UBR1 and UBR2 of the N-end rule pathway. 2004 |
| 41. Hiroyuki Yamamoto et al. Association of matrilysin-2 (MMP-26) expression with tumor progression and activation of MMP-9 in esophageal squamous cell carcinoma. 2004 |
| 42. Olga Kazanskaya et al. R-Spondin2 is a secreted activator of Wnt/beta-catenin signaling and is required for Xenopus myogenesis. 2004 |
| 43. David M Bryant et al. Regulation of endocytosis, nuclear translocation, and signaling of fibroblast growth factor receptor 1 by E-cadherin. 2005 |
| 44. Fumihiko Hamada et al. The APC tumor suppressor binds to C-terminal binding protein to divert nuclear beta-catenin from TCF. 2004 |
| 45. Guido T Bommer et al. DRO1, a gene down-regulated by oncogenes, mediates growth inhibition in colon and pancreatic cancer cells. 2005 |
| 46. Edith Hintermann et al. Integrin alpha6beta4-erbB2 complex inhibits haptotaxis by up-regulating E-cadherin cell-cell junctions in keratinocytes. 2005 |
| 47. Sang-Gu Hwang et al. Regulation of beta-catenin signaling and maintenance of chondrocyte differentiation by ubiquitin-independent proteasomal degradation of alpha-catenin. 2005 |
| 48. Nancy Gavert et al. L1, a novel target of beta-catenin signaling, transforms cells and is expressed at the invasive front of colon cancers. 2005 |
| 49. Dolly Mehta et al. Sphingosine 1-phosphate-induced mobilization of intracellular Ca2+ mediates rac activation and adherens junction assembly in endothelial cells. 2005 |
| 50. Usha Vadlamudi et al. PITX2, beta-catenin and LEF-1 interact to synergistically regulate the LEF-1 promoter. 2005 |
| 51. Miwako Nishizawa et al. Identification of trichoplein, a novel keratin filament-binding protein. 2005 |
| 52. Jungmook Lyu et al. Wnt-7a up-regulates matrix metalloproteinase-12 expression and promotes cell proliferation in corneal epithelial cells during wound healing. 2005 |
| 53. Roberta Benetti et al. The calpain system is involved in the constitutive regulation of beta-catenin signaling functions. 2005 |
| 54. Liem Thanh Tien et al. Expression of beta-catenin in hepatocellular carcinoma. 2005 |
| 55. Lina Sabatino et al. A novel peroxisome proliferator-activated receptor gamma isoform with dominant negative activity generated by alternative splicing. 2005 |
| 56. Jinyi Shao et al. Prostaglandin E2 Stimulates the beta-catenin/T cell factor-dependent transcription in colon cancer. 2005 |
| 57. Eri Mizuhara et al. MAGI1 recruits Dll1 to cadherin-based adherens junctions and stabilizes it on the cell surface. 2005 |
| 58. Thorsten Maretzky et al. ADAM10 mediates E-cadherin shedding and regulates epithelial cell-cell adhesion, migration, and beta-catenin translocation. 2005 |
| 59. Olivera Stojadinovic et al. Molecular pathogenesis of chronic wounds: the role of beta-catenin and c-myc in the inhibition of epithelialization and wound healing. 2005 |
| 60. Sima Salahshor et al. Differential gene expression profile reveals deregulation of pregnancy specific beta1 glycoprotein 9 early during colorectal carcinogenesis. 2005 |
| 61. Jianfei Qi et al. Transendothelial migration of melanoma cells involves N-cadherin-mediated adhesion and activation of the beta-catenin signaling pathway. 2005 |
| 62. Liang-Nian Song et al. Interaction of beta-catenin and TIF2/GRIP1 in transcriptional activation by the androgen receptor. 2005 |
| 63. Ji Zhang et al. Protein phosphatase 5 is required for ATR-mediated checkpoint activation. 2005 |
| 64. Catherine K Yang et al. Differential use of functional domains by coiled-coil coactivator in its synergistic coactivator function with beta-catenin or GRIP1. 2006 |
| 65. Qian Feng Han et al. Expression of sFRP-4 and beta-catenin in human colorectal carcinoma. 2006 |
| 66. Cathárine C Calkins et al. Desmoglein endocytosis and desmosome disassembly are coordinated responses to pemphigus autoantibodies. 2006 |
| 67. Polly J Phillips-Mason et al. The receptor protein-tyrosine phosphatase PTPmu interacts with IQGAP1. 2006 |
| 68. Long Zhang et al. Dapper 1 antagonizes Wnt signaling by promoting dishevelled degradation. 2006 |
| 69. T Pukrop et al. Wnt 5a signaling is critical for macrophage-induced invasion of breast cancer cell lines. 2006 |
| 70. Sylvia M Major et al. AbMiner: a bioinformatic resource on available monoclonal antibodies and corresponding gene identifiers for genomic, proteomic, and immunologic studies. 2006 |
| 71. Anja Persson et al. A human protein atlas based on antibody proteomics. 2006 |